Literature DB >> 23448608

Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.

Amina Valjevac1, Bakir Mehić, Emina Kiseljaković, Slavka Ibrulj, Agnieszka Garstka, Grażyna Adler.   

Abstract

Factor V is the liver-synthesized multidomain glycoprotein encoded by a gene localised on chromosome 1q23. The point mutation 1691G>A in this gene results in formation of an altered protein of V Factor resistant to activated protein C (APC) cleavage. This mutation alone is the most frequent cause of inborn thrombophilia and the most widely acknowledged genetic risk factor for venous thrombosis in a Caucasian population. This study was designed to provide the first estimate of the frequency of the allele 1691A FV in the Bosnian female population. The 1691G>A FV mutation was examined by polymerase chain reaction-restriction fragment length polymorphism, in a group of 67 women, mean age of 58.6 years with no history of cardiovascular incident. Our findings revealed an absence of the mutated allele 1691A FV in the studied group. This is the first report on the 1691G>A FV mutation in a population from Bosnia and Herzegovina. Further research is needed to establish prevalence of the mutated allele in the population from Bosnia and Herzegovina.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448608      PMCID: PMC4333927          DOI: 10.17305/bjbms.2013.2410

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  26 in total

1.  Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.

Authors:  Maria Teresa DeSancho; Nickisha Berlus; Paul J Christos; Jacob Rand
Journal:  Blood Coagul Fibrinolysis       Date:  2010-01       Impact factor: 1.276

2.  Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco.

Authors:  Thierry Paluku They-They; Khalil Hamzi; Mohamed Taha Moutawafik; Hanane Bellayou; Mariame El Messal; Sellama Nadifi
Journal:  Ann Hum Biol       Date:  2010-08-05       Impact factor: 1.533

3.  A rapid screening method for the factor V Arg506-->Gln mutation.

Authors:  S Gandrille; M Alhenc-Gelas; M Aiach
Journal:  Blood Coagul Fibrinolysis       Date:  1995-05       Impact factor: 1.276

4.  Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.

Authors:  B Zöller; B Dahlbäck
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

5.  Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women.

Authors:  Ayman S Hussein; Hisham Darwish; Khaled Shelbayeh
Journal:  Thromb Res       Date:  2010-06-01       Impact factor: 3.944

Review 6.  Thrombophilia in pregnancy: a systematic review.

Authors:  L Robertson; O Wu; P Langhorne; S Twaddle; P Clark; G D O Lowe; I D Walker; M Greaves; I Brenkel; L Regan; I A Greer
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

7.  Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.

Authors:  Ramzi R Finan; Hala Tamim; Ghada Ameen; Huda E Sharida; Mooza Rashid; Wassim Y Almawi
Journal:  Am J Hematol       Date:  2002-12       Impact factor: 10.047

8.  [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].

Authors:  K Kovacheva; P Ivanov; E Konova; M Simeonova; R Komsa-Penkova
Journal:  Akush Ginekol (Sofiia)       Date:  2007

Review 9.  [Thrombophilia, preeclampsia and other pregnancy complications].

Authors:  Niksa Vucić; Marina Frleta; Davor Petrović; Vedran Ostojić
Journal:  Acta Med Croatica       Date:  2009-10

10.  Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients.

Authors:  Raghid Kreidy
Journal:  Thrombosis       Date:  2012-06-12
View more
  2 in total

1.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

2.  Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina.

Authors:  Adna Ašić; Ramona Salazar; Niels Storm; Serkan Doğan; Wolfgang Höppner; Damir Marjanović; Dragan Primorac
Journal:  Croat Med J       Date:  2019-06-13       Impact factor: 1.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.